New Sensor Chip Shows Promise for Rapid, Low-Cost POC Disease Diagnostics
|
By LabMedica International staff writers Posted on 27 Jun 2023 |

The Loop-Mediated Isothermal Amplification (LAMP) technique is a popular method for identifying pathogens by amplifying their DNA. The detection of LAMP-amplified products, such as the DNA of pathogens, typically requires the use of fluorescent dyes to "label" these products, which can be expensive and have low sensitivity. Now, researchers have designed a new sensor capable of diagnosing pathogens without the need for these reagents and with a high degree of sensitivity. This new development also eliminates the time-consuming process of DNA purification, which often poses challenges for point-of-care applications.
Scientists at Texas A&M AgriLife Research (College Station, TX, USA) in collaboration with Iowa State University (Ames, IA, USA) have developed a sensor chip capable of identifying numerous disease-causing pathogens with ten times the sensitivity of existing techniques. The sensor chip eliminates the need for chemical dye reagents typically employed in diagnostics. The innovative chip consists of a nanopore thin-film sensor housed within a unique reaction chamber. Uniquely designed primers are immobilized on the nanofilm, causing the amplified LAMP products to bind to the sensor. The resulting signals can then be directly and easily measured using a portable spectrometer. The sensor delivers results within approximately 30 minutes. This new technology holds the promise of rapid, inexpensive point-of-care diagnostics in various sectors, including plants, food, animals, and human health, including the detection of foodborne pathogens, bird flu, and COVID-19.
In their study, the researchers used the innovative sensor to identify Phytophthora infestans, a pathogen that causes the highly destructive late blight disease, posing a significant threat to potato and tomato crops worldwide. The LAMP chip offers a new portable platform for pathogen detection, employing label-free sensors with exceptional sensitivity. The research team will now focus on increasing its sensitivity to the subattomolar levels or even lower. They aim to overcome the existing challenges in identifying and differentiating pathogen species and strains that share high sequence similarities. The team also plans to improve detection specificity and implement quantitative detection by integrating artificial intelligence and CRISPR gene-editing technologies. Their goal is to develop a feasible product for wide-ranging use in plant, animal, and human health point-of-care applications.
“This research advances technologies that have emerged as some of our greatest opportunities for improving agriculture, food safety and human health,” said Junqi Song, Ph.D., associate professor and plant immunity research lead with AgriLife Research. “Our publication represents a step toward realizing these powerful tools against diseases.”
Related Links:
Texas A&M AgriLife Research
Iowa State University
Latest Technology News
- Microfluidic Assay Predicts Treatment Response in Pediatric Leukemia
- AI Models Use Routine Blood Tests and Health Records to Predict Cancer Risk
- Compact PCR Thermal Cycler Launches for Routine Molecular Laboratory Workflows
- New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows
- Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
- Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
- New Automation Workflow Streamlines NGS Library Preparation for High-Volume Labs
- ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
- Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
- New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
- Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
- Autonomous Robotic System Receives FDA Authorization for Blood Collection
- Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
- Training Device Improves Accuracy of Pooled Molecular Diagnostics
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Channels
Clinical Chemistry
view channel
Blood Proteins Linked to Mortality Risk and Biological Aging Across Organ Systems
Older adults of the same chronological age can differ markedly in health, chronic disease burden, and resilience. Biological age aims to capture these differences by reflecting how rapidly the body and... Read more
Two-Step Blood Test Improves Specificity for Alzheimer’s Diagnosis
Early Alzheimer’s disease can be difficult to identify before more severe cognitive symptoms emerge. Blood tests measuring phosphorylated tau protein p-tau217 may help detect disease-related changes, but... Read moreHematology
view channel
Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification
Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more
New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL
Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read moreImmunology
view channel
Prototype Point-of-Care Lateral Flow Test Aims to Improve Neonatal Sepsis Triage
Sepsis in newborns and young infants remains a major clinical challenge, particularly in low- and middle-income countries. An estimated 2.3 million newborns die each year, with sepsis contributing substantially... Read more
Immune and Inflammatory Markers May Help Assess CAR T-Cell Complication Risk
Cytokine release syndrome (CRS) can occur after chimeric antigen receptor (CAR) T-cell therapy in patients with autoimmune disease. Identifying which patients are more likely to develop this complication... Read moreMicrobiology
view channel
Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea
Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more
Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response
The ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and neighboring countries has become one of the largest outbreaks of this Ebola virus species recorded to date.... Read morePathology
view channel
AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification
In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Roche Launches Automated Test to Support Mesothelioma Differential Diagnosis
Mesothelioma is a rare, deadly cancer that forms in the tissue lining many internal organs. Most patients are diagnosed late, with median overall survival reported at 12 to 18 months. Differential diagnosis... Read more
Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer
In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more
AI Pathology Tool Predicts DNA Repair Deficiency in High-Grade Serous Ovarian Cancer
High-grade serous tubo-ovarian carcinoma is an aggressive cancer arising in the ovaries or fallopian tubes. Some tumors exhibit homologous recombination deficiency (HRD), a feature reflecting impaired DNA repair.... Read moreTechnology
view channel
Microfluidic Assay Predicts Treatment Response in Pediatric Leukemia
Acute lymphoblastic leukemia (ALL) is a rapidly developing blood cancer that can disrupt production of mature infection-fighting white blood cells within months. More than 120,000 people in the U.... Read more
AI Models Use Routine Blood Tests and Health Records to Predict Cancer Risk
Cancer screening programs cover only certain cancers and often rely on broad eligibility criteria, limiting individualized risk assessment across multiple cancer types. Routine health data, including blood... Read moreIndustry
view channel
CE-Marked IVD Sequencing Platform Launches Across Ten EU Countries
Clinical laboratories using sequencing in regulated diagnostic workflows need systems that support clearly defined processes and documentation. In Europe, meeting applicable EU IVDR requirements also means... Read more







